Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma

OBJECTIVES: Hepatocyte growth factor (HGF) is a potential key factor in multiple myeloma. Conversion of pro-HGF to its active form is a critical limiting step for its biological effects. We aimed to examine the levels of the most potent activator, the hepatocyte growth factor activator (HGFA), in se...

Descripción completa

Detalles Bibliográficos
Autores principales: Wader, K F, Fagerli, U M, Holt, R U, Stordal, B, Børset, M, Sundan, A, Waage, A
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659365/
https://www.ncbi.nlm.nih.gov/pubmed/18691255
http://dx.doi.org/10.1111/j.1600-0609.2008.01130.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659365/
https://www.ncbi.nlm.nih.gov/pubmed/18691255
http://dx.doi.org/10.1111/j.1600-0609.2008.01130.x

Ejemplares similares